<p>Tenon Medical Inc. has provided preliminary revenue results for the fourth quarter and full year 2025, indicating significant growth in its business performance. The company expects fourth quarter 2025 revenue to range between $1.45 million and $1.48 million, representing approximately 90% year-over-year growth. For the full year 2025, Tenon forecasts revenue between $3.91 million and $3.94 million, reflecting around 20% year-over-year growth. The company highlighted strong commercial execution, expansion of its product portfolio, and the acquisition of sacroiliac joint-specific assets as key drivers of its improved financial results. Final audited numbers are expected to be reported in March 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1130613) on January 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

TNON

Reuters

Tenon Medical Projects Milestone Year in 2026 with Continued Revenue Growth